ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0945

Involvement of Cellular Senescence in Rheumatoid Arthritis-associated Interstitial Lung Disease of SKG Mice

Eri Watanabe1, Junko Nishio1, Tatsuma Ban2, Zento Yamada1, Tomohiko Tamura2 and Toshihiro Nanki1, 1Toho University, Tokyo, Japan, 2Yokohama City University, Yokohama, Japan

Meeting: ACR Convergence 2024

Keywords: interstitial lung disease, Mouse Models, RA, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: There has been accumulating evidence that cellular senescence of fibroblasts and alveolar epithelial cells contributes to inflammation and fibrosis through a senescence-associated secretory phenotype in idiopathic pulmonary fibrosis. However, the associations between cellular senescence and connective tissue disease-associated interstitial lung diseases (ILD) including rheumatoid arthritis-associated ILD (RA-ILD), remains unknown. Therefore, we explored the involvement of cellular senescence in the pathogenesis of RA-ILD using SKG/Jcl mice.

Methods: We induced ILD in 10-week-old male SKG/Jcl mice (SKG-ILD) via intraperitoneal administration of zymosan, and dissected lungs after 4, 8, or 12 weeks. Senescent cells were detected by immunohistochemistry using cellular senescence markers, p21WAF1/CIP1 (p21), p16INK4a (p16), and γ-H2A histone family member X (γ-H2AX). To explore cell populations expressing p21, we performed immunofluorescence and flow cytometry using the antibodies against p21 in combination with cell surface markers for immune cells (CD45), endothelial cells (CD31), and epithelial cells (epithelial cell adhesion molecule; EpCAM). Single cell RNA sequencing (scRNA-seq) was performed on whole cell suspensions from SKG-ILD and control lungs.

Results:  In immunohistochemistry, p21-expressing cells appeared in SKG-ILD lungs at 4 weeks after administering zymosan, and increased with the progression of ILD. Twelve weeks post-administration, p21, p16 and γ-H2AX were localized in the fibrosis foci of SKG-ILD lungs, whereas the proliferation marker Ki-67 was negative. Immunofluorescence revealed that most p21-postive cells in the fibrotic foci were CD45+ cells (Figure 1), and some were CD31+ cells, whereas very few were EpCAM+ cells. Flow cytometry demonstrated that among cells expressing p21 in SKG-ILD lungs, the CD45+ cells showed the highest percentage. The scRNA-seq revealed significantly higher expression of Cdkn1a (the gene encoding p21) in myeloid cells including interstitial macrophages (cluster 11), dendritic cells (cluster 4) and neutrophils (clusters 2 and 6), and endothelial cells (clusters 1 and 13) in SKG-ILD lungs (Figure 2). Notably, cells in cluster 6, which were almost exclusively observed in SKG-ILD lungs and scarcely in control lungs, highly expressed interferon-stimulated genes such as Ifit3 and Isg15.

Conclusion: This study is the first to investigate the association of cellular senescence with RA-ILD using SKG-ILD. Our findings suggested that in SKG-ILD lungs, myeloid cells including interstitial macrophages, dendritic cells, neutrophils, and endothelial cells, may undergo cellular senescence, and play a role in the pathogenesis of RA-ILD.

Supporting image 1

Figure 1. p21 was expressed in some CD45+ cells localized in fibrosis foci of SKG-ILD lungs.
SKG-ILD lung tissue was stained for CD45 (red), p21 (green), and DAPI (blue) by immunofluorescence.

Supporting image 2

Figure 2. Single cell RNA sequencing on whole cell suspension of SKG-ILD lungs.
(A) UMAP visualization for control and SKG-ILD lungs. (B) Expression of Cdkn1a in clusters 4, 11, 2, 6, 1 and 13.
DC, dendritic cell; IM, interstitial macrophage; Neu, neutrophil; EC, endothelial cell.


Disclosures: E. Watanabe: Bayer, 5; J. Nishio: Abbott Japan LLC., 5, AbbVie GK, 5, Asahikasei Pharma Corp., 5, Ayumi Pharmaceutical Corp., 5, Chugai Pharmaceutical Co., Ltd, 5, Eisai Co., Ltd., 5, Nippon Boehringer Ingelheim Co.,Ltd., 5, Nippon Kayaku Co., 5, Ono Pharmaceutical Co., Ltd., 5, Taisho Pharmaceutical Co., Ltd., 5; T. Ban: None; Z. Yamada: None; T. Tamura: None; T. Nanki: Abbott Japan LLC., 5, AbbVie GK, 5, 6, Asahikasei Pharma Corp., 5, 6, Astellas Pharma Inc., 6, AstraZeneca K.K., 6, Ayumi Pharmaceutical Corp., 5, 6, Bristol Myers Squibb Co., 5, Chugai Pharmaceutical Co., Ltd, 2, 5, 6, Daiichi Sankyo Co., Ltd., 6, Eisai Co., Ltd., 5, 6, Eli Lilly Japan K.K., 5, 6, Janssen Pharmaceutical K.K., 6, Mitsubishi Tanabe Pharma Corp., 5, 6, Nippon Boehringer Ingelheim Co.,Ltd., 5, 6, Nippon Kayaku Co., 5, Ono Pharmaceutical Co., Ltd., 5, 6, Pfizer Japan Inc., 6, Shionogi & Co., Ltd., 5, Taisho Pharmaceutical Co., Ltd., 5, 6, UCB Japan Co. Ltd., 2, 6.

To cite this abstract in AMA style:

Watanabe E, Nishio J, Ban T, Yamada Z, Tamura T, Nanki T. Involvement of Cellular Senescence in Rheumatoid Arthritis-associated Interstitial Lung Disease of SKG Mice [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/involvement-of-cellular-senescence-in-rheumatoid-arthritis-associated-interstitial-lung-disease-of-skg-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/involvement-of-cellular-senescence-in-rheumatoid-arthritis-associated-interstitial-lung-disease-of-skg-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology